John Reynolds

John Reynolds, MD, serves as an IACUC Board Member at Burleson Research Technologies since February 2024 and as a Scientific Reviewer for the Alternatives Research & Development Foundation since January 2021. This role involves reviewing grants for a foundation focused on promoting non-animal research methods. Additionally, John is a Board Member of the Public Art Advisory Board for the Town of Cary since October 2019. Previous positions include Vice President of Global Product Safety at Merz Aesthetics, Executive Medical Director for Safety Evaluation and Risk Management at GSK Consumer Healthcare, and Executive Medical Director of Pharmacovigilance at Pfizer. John has extensive experience in medical, regulatory, and pharmacovigilance services, with a history at Kraken Consulting, Talecris Biotherapeutics, Abraxis BioScience, and Ashfield. Academic credentials include a Doctor of Medicine (MD) and a Bachelor of Science (BS) in Chemistry and Psychology from the University of North Carolina at Chapel Hill.